Efficacy and Safety of Etrolizumab in the Treatment of Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Author:

Jaber Fouad1ORCID,Alsakarneh Saqr12,Ayyad Mohammed2,Alsharaeh Tala3,Salahat Ahmed-Jordan3,Jaber Mohammad4,Kilani Yassine5,Aldiabat Mohammad67,Gangwani Manesh Kumar8,Abboud Yazan9,Fares Ahmed10,Dahiya Dushyant Singh11,Ahmed Mohamed12,Shukla Richa13

Affiliation:

1. Department of Medicine, University of Missouri-Kansas City, Kansas City, MO

2. Faculty of Medicine, Al-Quds University, Jerusalem, Palestine

3. Department of Medicine, The University of Jordan - Faculty of Medicine, Amman, Jordan

4. Department of Medicine, Al-Azhar University - Faculty of Medicine, Gaza, Palestine

5. Department of Internal Medicine, NYC Health + Hospitals, Lincoln - Weill Cornell Medical College, Bronx, NY

6. Department of Epidemiology, Harvard School of Public Health, Boston, MA

7. Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO

8. Department of Internal Medicine, University of Toledo, Toledo, OH

9. Department of Internal Medicine, Rutgers New Jersey Medical School, Newark, NJ

10. Department of Medicine, Tufts Medical Center, Boston, MA

11. Division of Gastroenterology Hepatology & Motility, The University of Kansas School of Medicine, Kansas City, KS

12. Division of Gastroenterology, University of Missouri-Kansas City, Kansas City, MO

13. Department of Medicine, Section of Gasteroenterology and Hepatology, Baylor College of Medicine, Houston, TX

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3